Our clinical studies for Alzheimer's Disease are overseen by the FDA and aim to determine the effectiveness of investigational medications in volunteers with Alzheimer's. Eligible candidates will receive, at no cost, study-related evaluation, care and medication. Reimbursement for time and travel may also be provided to qualified participants. Studies vary, but typically require regular visits to the office over a 12 to 26 week period. All visits are conducted at our office in a comfortable and professional setting. Apply now to learn more and determine if one of our studies may be right for you.